-
1
-
-
12944271053
-
Cancer statistics, 2005
-
Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 10-30
-
-
Jemal, A.1
Murray, T.2
Ward, E.3
-
2
-
-
1642588228
-
Pancreatic cancer
-
Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet 2004;363:1049-57.
-
(2004)
Lancet
, vol.363
, pp. 1049-1057
-
-
Li, D.1
Xie, K.2
Wolff, R.3
-
3
-
-
0031934765
-
Role of growth factors in pancreatic cancer
-
Korc M. Role of growth factors in pancreatic cancer. Surg Oncol Clin N Am 1998;7:25-41.
-
(1998)
Surg Oncol Clin N Am
, vol.7
, pp. 25-41
-
-
Korc, M.1
-
5
-
-
0024371484
-
Binding of heparan sulfate to type V collagen. A mechanism of cell-substrate adhesion
-
LeBaron RG, Hook A, Esko JD, et al. Binding of heparan sulfate to type V collagen. A mechanism of cell-substrate adhesion. J Biol Chem 1989;264:7950-6.
-
(1989)
J Biol Chem
, vol.264
, pp. 7950-7956
-
-
LeBaron, R.G.1
Hook, A.2
Esko, J.D.3
-
6
-
-
0028907307
-
Heparan sulfate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells
-
Stanley MJ, Liebersbach BF, Liu W, et al. Heparan sulfate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells. J Biol Chem 1995;270:5077-83.
-
(1995)
J Biol Chem
, vol.270
, pp. 5077-5083
-
-
Stanley, M.J.1
Liebersbach, B.F.2
Liu, W.3
-
7
-
-
0027292970
-
Integral membrane heparan sulfate proteoglycans
-
David G. Integral membrane heparan sulfate proteoglycans. FASEB J 1993;7:1023-30.
-
(1993)
FASEB J
, vol.7
, pp. 1023-1030
-
-
David, G.1
-
8
-
-
0028936927
-
Regulation by heparan sulfate in fibroblast growth factor signaling
-
Rapraeger AC, Guimond S, Krufka A, et al. Regulation by heparan sulfate in fibroblast growth factor signaling. Methods Enzymol 1994;245:219-40.
-
(1994)
Methods Enzymol
, vol.245
, pp. 219-240
-
-
Rapraeger, A.C.1
Guimond, S.2
Krufka, A.3
-
9
-
-
0030979023
-
Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors
-
Bonneh-Barkay D, Shlissel M, Berman B, et al. Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors. J Biol Chem 1997;272:12415-21.
-
(1997)
J Biol Chem
, vol.272
, pp. 12415-12421
-
-
Bonneh-Barkay, D.1
Shlissel, M.2
Berman, B.3
-
10
-
-
0029098698
-
Increased mitogenic response to heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells of diabetic rats
-
Fukuda K, Inui Y, Kawata S, et al. Increased mitogenic response to heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells of diabetic rats. Arterioscler Thromb Vasc Biol 1995;15:1680-7.
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 1680-1687
-
-
Fukuda, K.1
Inui, Y.2
Kawata, S.3
-
11
-
-
0031002920
-
Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling
-
Sakata H, Stahl SJ, Taylor WG, et al. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J Biol Chem 1997;272:9457-63.
-
(1997)
J Biol Chem
, vol.272
, pp. 9457-9463
-
-
Sakata, H.1
Stahl, S.J.2
Taylor, W.G.3
-
12
-
-
0033856662
-
Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers
-
Conejo JR, Kleeff J, Koliopanos A, et al. Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers. Int J Cancer 2000;88:12-20.
-
(2000)
Int J Cancer
, vol.88
, pp. 12-20
-
-
Conejo, J.R.1
Kleeff, J.2
Koliopanos, A.3
-
13
-
-
0032213027
-
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer
-
Kleeff J, Ishiwata T, Kumbasar A, et al. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest 1998;102:1662-73.
-
(1998)
J Clin Invest
, vol.102
, pp. 1662-1673
-
-
Kleeff, J.1
Ishiwata, T.2
Kumbasar, A.3
-
14
-
-
0032876483
-
Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells
-
Kleeff J, Wildi S, Kumbasar A, et al. Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells. Pancreas 1999;19:281-8.
-
(1999)
Pancreas
, vol.19
, pp. 281-288
-
-
Kleeff, J.1
Wildi, S.2
Kumbasar, A.3
-
15
-
-
0037147259
-
Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans
-
Morimoto-Tomita M, Uchimura K, Werb Z, et al. Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem 2002;277:49175-85.
-
(2002)
J Biol Chem
, vol.277
, pp. 49175-49185
-
-
Morimoto-Tomita, M.1
Uchimura, K.2
Werb, Z.3
-
16
-
-
0038677717
-
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer
-
Lai J, Chien J, Staub J, et al. Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. J Biol Chem 2003;278:23107-17.
-
(2003)
J Biol Chem
, vol.278
, pp. 23107-23117
-
-
Lai, J.1
Chien, J.2
Staub, J.3
-
17
-
-
1442357192
-
HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma
-
Lai JP, Chien J, Strome SE, et al. HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene 2004;23:1439-47.
-
(2004)
Oncogene
, vol.23
, pp. 1439-1447
-
-
Lai, J.P.1
Chien, J.2
Strome, S.E.3
-
18
-
-
9144264904
-
hSulf1 sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling
-
Lai JP, Chien JR, Moser DR, et al. hSulf1 sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology 2004;126:231-48.
-
(2004)
Gastroenterology
, vol.126
, pp. 231-248
-
-
Lai, J.P.1
Chien, J.R.2
Moser, D.R.3
-
19
-
-
26844545446
-
Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
-
Li J, Kleeff J, Abiatari I, et al. Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer. Mol Cancer 2005;4:14.
-
(2005)
Mol Cancer
, vol.4
, pp. 14
-
-
Li, J.1
Kleeff, J.2
Abiatari, I.3
-
20
-
-
0027361196
-
The cell proliferation-associated antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins
-
Schluter C, Duchrow M, Wohlenberg C, et al. The cell proliferation- associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 1993;123:513-22.
-
(1993)
J Cell Biol
, vol.123
, pp. 513-522
-
-
Schluter, C.1
Duchrow, M.2
Wohlenberg, C.3
-
21
-
-
0032851160
-
Functions of cell surface heparan sulfate proteoglycans
-
Bernfield M, Gotte M, Park PW, et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999;68:729-77.
-
(1999)
Annu Rev Biochem
, vol.68
, pp. 729-777
-
-
Bernfield, M.1
Gotte, M.2
Park, P.W.3
-
22
-
-
12344310615
-
Functions of heparan sulfate proteoglycans in cell signaling during development
-
Lin X. Functions of heparan sulfate proteoglycans in cell signaling during development. Development 2004;131:6009-21.
-
(2004)
Development
, vol.131
, pp. 6009-6021
-
-
Lin, X.1
-
23
-
-
28844483193
-
HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo
-
Dai Y, Yang Y, MacLeod V, et al. HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. J Biol Chem 2005;280:40066-73.
-
(2005)
J Biol Chem
, vol.280
, pp. 40066-40073
-
-
Dai, Y.1
Yang, Y.2
MacLeod, V.3
|